Related Experiment Video
Updated: Jul 2, 2025

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
Published on: October 16, 2018
The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers
Carmen Gasca-Capote1, Xiaodong Lian2,3, Ce Gao2,3
1Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, Spanish National Research Council (CSIC), University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain.
Persistent controllers (PCs) maintain long-term HIV-1 control without antiretroviral therapy (ART), unlike transient controllers (TCs). This study reveals distinct HIV reservoir characteristics in PCs and TCs, guiding future HIV cure research.
Area of Science:
- Virology
- Immunology
- Genetics
Background:
- Persistent controllers (PCs) achieve indefinite antiretroviral-free HIV-1 control.
- Transient controllers (TCs) eventually lose virological control.
- Understanding HIV reservoir quality is key to preventing progression and finding a cure.
Purpose of the Study:
- To characterize the HIV-1 reservoir in persistent and transient controllers.
- To identify factors contributing to HIV progression and inform cure strategies.
Main Methods:
- Peripheral blood mononuclear cells were analyzed using next-generation sequencing.
- Full-length individual and matched integration site proviral sequencing (FLIP-Seq; MIP-Seq) were employed.
Main Results:
- PCs and TCs had lower total, intact, and defective proviruses than those on ART.
- Intact provirus levels were lower in PCs than TCs, with a higher intact/defective ratio in TCs.
- Clonally expanded intact proviruses in PCs were in heterochromatic regions; in TCs, they were in euchromatic positions.
Conclusions:
- Distinct proviral landscapes may be associated with persistent HIV-1 control without ART.
- These findings guide future research into the mechanisms of sustained HIV control.
- Identifying these distinct features is crucial for developing novel HIV cure interventions.
More Related Videos
07:18High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011